Tizanidine Tablet
Product Images NDC 63629-1673
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 63629-1673). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Fig2 (Fig2)
Fig3 (Fig3)
The text describes a study on the medication zanidine, which is being used to improve the Ashworth Score of patients. The dose of zanidine being used is 28.6 mg. The study is being conducted over a period of 7 weeks, with the primary endpoint being at week 3, and the end of maintenance endpoint being at week 7, using the last observation carried forward method.*
Label Image (Lbl636291673)
This text contains some medication information for a drug called Zanaflex 4mg Tablet. It suggests to store the medication at room temperature of 20-25°C (68-77°F). It also warns that the medication may cause drowsiness and provides some details about the manufacturer, the expiration date, and a National Drug Code (NDC) number. However, the relevance of the mention of "Awox" is not clear from the given text.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.